References
- Burney I A, Siddigui T. Serum CA-125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity [letter]. Cancer 1999; 85: 755–756
- Ozguroglu M, Turna H, Demir G, Doventas B, Demirelli F, Mandel N, et al. Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma. Am J Clin Oncol 1999; 22: 615–618
- Kutluk T, Varan A, Erbas B, Buyukpamuk M. Serum CA125 levels in children with non-Hodgkin's lymphoma. Pediatr Hematol Oncol 1999; 16: 311–319
- Morra E. The biological markers of Non-Hodgkin's lymphomas: their role in diagnosis, prognostic assessment and therapeutic strategy. Int J Biol Markers 1999; 14: 149–153
- Yerushalmi R, Rakowsky E, Sulkes A. Rising CA-125 levels in a patient with ovarian cancer are not always indication of disease recurrence. Harefuah 2002; 141: 347–348
- Zidan J, Hussein O, Basher W, Zohar S. Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma. Oncologist 2004; 9: 417–421
- Bairey O, Blicktein D, Stark P, Prokocimer M, Nativ H M, Kirgner I, et al. Serum CA125 as a prognostic factor in non-Hodgkin's lymphoma. Leuk Lymphoma 2003; 44: 1733–1738
- Benboubker L, Valat C, Linassier C, Cartron G, Delain M, Bout M, et al. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA-125 and LDH serum levels. Ann Oncol 2000; 11: 1485–1491
- Zacharos I D, Efstathiou S P, Petreli E, Georgiou G, Tsioulos D I, Mastorantonakis S E, et al. The prognostic significance of CA-125 in patients with non-Hodgkin's lymphoma. Eur J Haematol 2002; 69: 221–226
- Kajiume T, Yoshimi S, Kobayashi K, Kataoka N. A case of malignant lymphoma in a patient with high level of CA-125 and CA19-9. Pediatr Hematol Oncol 2000; 17: 269–272
- Dilek I, Ayakta H, Demir C, Meral C, Ozturk M. CA125 levels in patients with non-Hodgkin lymphoma and other hematologic malignancies. Clin Lab Haematol 2005; 27: 51–55
- Lazzarino M, Orlandi E, Klersy C, Astori C, Brusamolino E, Corso A, et al. Serum CA-125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. Cancer 1998; 82: 576–582
- Apel R L, Fernandes B J. Malignant lymphoma presenting with an elevated serum CA-125 level. Arch Pathol Lab Med 1995; 119: 373–376
- Vlasveld L T, Ermens A A, Sonnenberg A A, Pauwels P. Elevated serum CA-125 concentrations due to expression by a diffuse large B-cell lymphoma. Ann Clin Biochem 2000; 37: 545–548
- Kubonishi I, Bandobashi K, Murata N, Daibata M, Ido E, Sonobe H, et al. High serum levels of CA-125 and interleukin-6 in a patient with ki-1 lymphoma. Br J Haematol 1997; 98: 450–452